Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (9,706,490)	$ (16,541,695)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	36,123	38,539
Stock-based compensation	2,121,888	5,961,543
Provision for losses on accounts receivable	0	50,079
Changes in operating assets and liabilities:
Accounts receivable	(256,185)	(42,328)
Insurance and Security deposits	47,103	654,454
Other current assets	529,506	103,557
Accounts payable	(1,216,999)	838,775
Accrued liabilities	633,707	1,267,927
Insurance reserve	(59,637)	(122,557)
Deferred revenue	113	(12,991)
Right of use assets and liabilities, net	16,628	0
Net cash used in operating activities	(7,854,243)	(7,804,697)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of intangible assets	(208,462)	0
Net cash used in investing activities	(208,462)	0
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from sale of common stock	0	29,727,500
Offering costs associated with public offering	0	(2,126,305)
Proceeds from exercise of stock options	0	114,896
Proceeds from exercise of warrants	0	64,540
Net cash provided by financing activities	0	27,780,631
Increase (decrease) in cash, cash equivalents and restricted cash	(8,062,705)	19,975,934
Cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash - beginning of period	14,747,407	4,923,515
Cash, cash equivalents and restricted cash - end of period	6,684,702	24,899,449
Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets
Cash and cash equivalents	3,573,595	24,021,863
Restricted cash	3,111,107	877,586
Total cash, and cash equivalents and restricted cash to the consolidated balance sheets	6,684,702	24,899,449
Supplemental disclosures of cash flow information:
Interest expense	0	0
Income taxes	800	800
Non-cash investing and financing activities:
Right of use asset and liability	$ 997,109	$ 0